- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 44.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 44.26M sh |
| Shares Diluted | Q1 2026 · Mar 30, 2025 | 45.93M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 30, 2025 | $300M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $15.05M |
| Dividends Paid | Q1 2026 · Mar 30, 2025 | $15.19M |
| Capex | Q1 2026 · Mar 31, 2026 | $18.79M |
| Capex restated | Q1 2026 · Mar 30, 2025 | $24.13M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.51B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.54B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $309.41M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $378.56M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.08B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.12B |
| Stockholders Equity | Q1 2026 · Mar 30, 2025 | $4.1B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.28B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $728.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $762.03M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.7B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.82B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.86B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.94B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.78B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.95B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 30, 2025 | $2.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 30, 2025 | $2.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $226.01M |
| Sga Expense restated | Q1 2026 · Mar 30, 2025 | $152.91M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $44.39M |
| Rd Expense restated | Q1 2026 · Mar 30, 2025 | $25.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.15M |
| Net Income | Q1 2026 · Mar 30, 2025 | $95M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $20.18M |
| Operating Income restated | Q1 2026 · Mar 30, 2025 | $75.8M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $307.43M |
| Gross Profit restated | Q1 2026 · Mar 30, 2025 | $255.43M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $240.84M |
| Cost Of Revenue restated | Q1 2026 · Mar 30, 2025 | $158.83M |
| Revenue | Q1 2026 · Mar 31, 2026 | $548.26M |
| Revenue restated | Q1 2026 · Mar 30, 2025 | $414.26M |